Pharus Diagnostics
PrivateLast Round
Early Funding
May 4, 2025
Est. Valuation
$30M
Total Funding Raised
$11M
Company Overview
Pharus Diagnostics operates in Healthcare & Life Sciences and is based in Taiwan. Its latest recorded funding round was a Series A Extension round in July 2022.
Pharus Diagnostics is a biotechnology company that develops liquid biopsy tests for the early detection of cancer using proprietary RNA-based technology and machine learning.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Medical AI, Healthcare Analytics
Business Model
B2B
Customer Profile
Usage-Based SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Pharus Diagnostics Comparables
Compare Pharus Diagnostics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Amplified Sciences | 81% | |
| Mercy BioAnalytics | 77% | |
| Singlera Genomics Inc. | 77% |
For institutional investors. Book with your work email.
Pharus Diagnostics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Funding | May 4, 2025 | ||||
| Series A Extension | Jul 25, 2022 | ||||
| VC Round | Jul 1, 2022 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- May 4, 2025
Completed an early funding round.
- May 2, 2025
Monthly visitors grew 176% MoM, reaching 2.1K.
For institutional investors. Book with your work email.
Pharus Diagnostics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Pharus Diagnostics's valuation, stock price, and market status.
Is Pharus Diagnostics a public or private company?
Pharus Diagnostics is a private company.
What is the current stock price of Pharus Diagnostics?
Pharus Diagnostics is a private company, so its shares have no public market price. Caplight tracks Pharus Diagnostics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Pharus Diagnostics worth (valuation)?
Pharus Diagnostics's valuation is estimated at $30.0M based on funding round data.
Can I buy Pharus Diagnostics stock?
Pharus Diagnostics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Pharus Diagnostics's last funding round?
Pharus Diagnostics's most recent funding round was Early Funding on May 4, 2025.
Who are the main investors in Pharus Diagnostics?
Investor information for Pharus Diagnostics is not publicly disclosed.
Will Pharus Diagnostics IPO soon?
No public IPO plans have been announced for Pharus Diagnostics.
How can I track Pharus Diagnostics secondary market activity?
Caplight tracks bids, offers, and trades in Pharus Diagnostics's shares on secondary markets.